About: MICHAEL WARD
- Website
- http://apreconasia.wordpress.com
- Details
- Medical Device Industry veteran on a global basis, with a soupcon of pharmaceutical and biologics experience. Myriad of senior leadership roles in all phases of product development. Master of clinical design, protocol development, regulatory compliance pathways - GxP, SOPs, QA. Other expertise includes clinical/business initiatives in China, hemostasis/thrombosis, neurosciences, cardiovascular therapies, and new business development.
Posts by MICHAEL WARD:
Follow Blog via Email
Join 2,038 other subscribers-
Recent Posts
- Novartis and Bristol Myers Squibb halt CAR-T trial for autoimmune diseases over patient deaths: a potential issue with cell-based manufacturing September 15, 2026
- FDA Contemplates Changes in Trial Design, Drug Development, and Use of AI in Clinical Trials September 15, 2026
- FDA Moves Forward With Its Guidance Framework for Rare Disease Trials: 2026 August 3, 2026
- Artificial Intelligence TRANSFORMS Medicine, Biotech and Healthcare, How? August 3, 2026
- In Memoriam: Nobel Laureate J. Michael Bishop for discovery of Retroviral Oncogenes July 31, 2026
- Companies Actively Engaging Artificial Intellegence for Drug Design: 2026 July 31, 2026
- AI-Native Drug Discovery Landscape 2026 – How LPBI Group Differentiates in the New Era of Foundation Models July 19, 2026
- In Memoriam: In Remembrance of Cancer Researchers who passed in 2026 July 13, 2026
- Urgent Request for Action on Proposed Rule Affecting Federal Funding Grant Review July 7, 2026
- 2026 Tang Prize in Biopharmaceutical Science Awarded to Three Pioneers of Cellular Immunotherapy Revolutionizing Treatments for Blood Cancers and Solid Tumors July 5, 2026
Archives
Categories
Meta
2012pharmaceutical
sjwilliamspa